Foresite Capital Fund IV, L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE)

Filing Manager
Foresite Capital Fund IV, L.P.
Reporting Manager
James Tananbaum
Security
Maze Therapeutics, Inc. Common Stock, par value $0.001
Symbol
MAZE
Shares outstanding
43.5M shares
Disclosed Ownership
609K shares
Ownership
1.4%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 04:04 PM
Date of event
Sep 30, 2025
Previous filing
Feb 7, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foresite Capital Fund IV, L.P. 1.2% 523K 523K 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management IV, LLC 1.2% 523K 523K 0 /s/ James Tananbaum James Tananbaum, Managing Member
Foresite Capital Fund V, L.P. 0.2% 86.3K 86.3K 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management V, LLC 0.2% 86.3K 86.3K 0 /s/ James Tananbaum James Tananbaum, Managing Member
James Tananbaum 1.4% 609K 609K 0 /s/ James Tananbaum James Tananbaum